Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.

A conversation with Novartis Chief Digital Officer Bertrand Bodson

Cambridge neighbors, NIBR and Harvard, further disrupt technology. Read how their alliance is accelerating drug discovery.

Novartis researchers are peering deep inside knees to see if regenerated cartilage is springy like natural cartilage.

Pneumatic tube systems have existed for 150+ years and have transported everything from telegrams to aircraft parts. Now they’re being used in our labs.

In Wendi Yajnik’s quest to find new technologies that could transform medicine, relationships are priority No. 1.

Molecular glues are a new type of medicine inspired by nature’s matchmakers.

Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.

Novartis researchers are working to extend the life of organ transplants

Phil Gotwals talks about his vision for the future of business development for research.

Novartis investigators find genetic explanations for why some young patients relapse.

Researchers from industry and academia will leverage new chemistry to hit difficult drug targets.